Visitor information – Everything you need to know about visiting our sites.
Alfred Health research outcomes are published in a wide range of peer reviewed journals.
Search or browse research publications by year, research area, publication type or keyword.
Publication Details
COVID-19 and the Indo-Pacific: implications for resource-limited emergency departments
Woodruff IG, Mitchell RD, Phillips G, Sharma D, Toito'ona P, Jayasekera K, Wah KS, Cox M, O'Reilly GM
(2020), MED J AUSTRALIA, 213(8), 345-9.e1
DOI: 10.5694/mja2.50750
Combined ipilimumab and nivolumab first-line and after BRAF-targeted therapy in advanced melanoma
Mason R, Dearden HC, Nguyen B, Soon JA, Smith JL, Randhawa M, Mant A, Warburton L, Lo S, Meniawy T, Guminski A, Parente P, Ali S, Haydon A, Long GV, Carlino MS, Millward M, Atkinson VG, Menzies AM
(2020), PIGM CELL MELANOMA R, 33(2), 358-65
DOI: 10.1111/pcmr.12831
Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo: A Secondary Analysis of a Randomized Clinical Trial
Eggermont AMM, Kicinski M, Blank CU, Mandala M, Long GV, Atkinson V, Dalle S, Haydon A, Khattak A, Carlino MS, Sandhu S, Larkin J, Puig S, Ascierto PA, Rutkowski P, Schadendorf D, Koornstra R, Hernandez-Aya L, Di Giacomo AM, van den Eertwegh AJM, Grob JJ, Gutzmer R, Jamal R, Lorigan PC, Krepler C, Ibrahim N, Marreaud S, van Akkooi A, Robert C, Suciu S
(2020), JAMA Oncol, 6(4), 519-27
Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors
Desai J, Gan H, Barrow C, Jameson M, Atkinson V, Haydon A, Millward M, Begbie S, Brown M, Markman B, Patterson W, Hill A, Horvath L, Nagrial A, Richardson G, Jackson C, Friedlander M, Parente P, Tran B, Wang L, Chen Y, Tang Z, Huang W, Wu J, Zeng D, Luo L, Solomon B
(2020), J Clin Oncol, 38(19), 2140-50
DOI: 10.1200/JCO.19.02654
Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy
Owen CN, Shoushtari AN, Chauhan D, Palmieri DJ, Lee B, Rohaan MW, Mangana J, Atkinson V, Zaman F, Young A, Hoeller C, Hersey P, Dummer R, Khattak MA, Millward M, Patel SP, Haydon A, Johnson DB, Lo S, Blank CU, Sandhu S, Carlino MS, Larkin JMG, Menzies AM, Long GV
(2020), Ann Oncol, 31(8), 1075-82
Treatment of High Risk Resected Melanoma in Australia: Current Landscape and Practises
Bhave P, Haydon A
(2020), Australas J Dermatol, 61(3), 203-9
DOI: 10.1111/ajd.13309
Caution in the age of optimism; a salient lesson in advanced melanoma
Roberts HN, Haydon A
(2020), Ann Transl Med, 8(11), 720
Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma
Dummer R, Hauschild A, Santinami M, Atkinson V, Mandalà M, Kirkwood JM, Chiarion Sileni V, Larkin J, Nyakas M, Dutriaux C, Haydon A, Robert C, Mortier L, Schachter J, Lesimple T, Plummer R, Dasgupta K, Gasal E, Tan M, Long GV, Schadendorf D
(2020), NEW ENGL J MED, 383(12), 1139-48
Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial
Eggermont AMM, Blank CU, Mandala M, Long GV, Atkinson VG, Dalle S, Haydon AM, Meshcheryakov A, Khattak A, Carlino MS, Sandhu S, Larkin J, Puig S, Ascierto PA, Rutkowski P, Schadendorf D, Koornstra R, Hernandez-Aya L, Di Giacomo AM, van den Eertwegh AJM, Grob JJ, Gutzmer R, Jamal R, Lorigan PC, van Akkooi ACJ, Krepler C, Ibrahim N, Marreaud S, Kicinski M, Suciu S, Robert C
(2020), J Clin Oncol, 38(33), 3925-36
DOI: 10.1200/JCO.20.02110
Eftilagimod alpha, a soluble lymphocyte activation gene-3 (LAG-3) protein plus pembrolizumab in patients with metastatic melanoma
Atkinson V, Khattak A, Haydon A, Eastgate M, Roy A, Prithviraj P, Mueller C, Brignone C, Triebel F
(2020), J Immunother Cancer, 8(2), e001681
Clinimetrics: The Intensive Care Unit Mobility Scale
Tipping CJ, Hodgson CL
(2020), J Physiother, 66(4), 271
Physiotherapy management for COVID-19 in the acute hospital setting: clinical practice recommendations
Thomas P, Baldwin C, Bissett B, Boden I, Gosselink R, Granger CL, Hodgson C, Jones AY, Kho ME, Moses R, Ntoumenopoulos G, Parry SM, Patman S, van der Lee L
(2020), J Physiother, 66(2), 73-82
Progressive active mobilization with dose control and training load in critically ill patients (PROMOB): Protocol for a randomized controlled trial
Queiroz RS, Saquetto MB, Martinez BP, Cazeta BBR, Hodgson C, Gomes-Neto M
(2020), PLoS One, 15(9), e238352
Survival and functional outcome at hospital discharge following in-hospital cardiac arrest (IHCA): A prospective multicentre observational study
Pound G, Jones D, Eastwood GM, Paul E, Hodgson CL; ANZ-CODE Investigators
(2020), Resuscitation, 155, 48-54
A survey of extracorporeal membrane oxygenation practice in 23 Australian adult intensive care units
Linke NJ, Fulcher BJ, Engeler DM, Anderson S, Bailey MJ, Bernard S, Board JV, Brodie D, Buhr H, Burrell AJC, Cooper DJ, Fan E, Fraser JF, Gattas DJ, Higgins AM, Hopper IK, Huckson S, Litton E, McGuinness SP, Nair P, Orford N, Parke RL, Pellegrino VA, Pilcher DV, Sheldrake J, Reddi BAJ, Stub D, Trapani TV, Udy AA, Hodgson CL; EXCEL Investigators
(2020), Crit Care Resusc, 22(2), 166-70
Clinical Practice Guidelines for Early Mobilization in the ICU: A Systematic Review
Lang JK, Paykel MS, Haines KJ, Hodgson CL
(2020), Crit Care Med, 48(11), e1121-8
Fat embolism syndrome: Experience from an Australian trauma centre
Kirk A, Elliott J, Varma D, Kimmel L
(2020), International Journal of Orthopaedic and Trauma Nursing, 36, 100746
High-Flow Nasal Cannula Compared With Conventional Oxygen Therapy or Noninvasive Ventilation Immediately Postextubation: A Systematic Review and Meta-Analysis
Granton D, Chaudhuri D, Wang D, Einav S, Helviz Y, Mauri T, Mancebo J, Frat JP, Jog S, Hernandez G, Maggiore SM, Hodgson CL, Jaber S, Brochard L, Trivedi V, Ricard JD, Goligher EC, Burns KEA, Rochwerg B
(2020), Crit Care Med, 48(11), e1129-e1136
The perceived barriers and facilitators to implementation of ECMO services in acute hospitals
Fulcher BJ, Nicholson AJ, Linke NJ, Berkovic D, Hodgson CL; EXCEL Study Investigators and the International ECMO Network
(2020), INTENS CARE MED, 46(11), 2115-7
Physical activity for cystic fibrosis: perceptions of people with cystic fibrosis, parents and healthcare professionals
Denford S, Cox NS, Mackintosh KA, McNarry MA, O'Halloran P, Holland AE, Tomlinson OW, Barker AR, Williams CA
(2020), ERJ Open Research, 6(3), 00029-2019